Arab World vs Sweden: Access to anti-retroviral drugs, female
Arab World
48.4%
in 2024
Sweden
96.0%
in 2022
Arab World rank
16th
Sweden rank
14th
Access to anti-retroviral drugs, female over time
- Arab World
- Sweden
How they compare
Sweden currently reports 96.0% against 48.4% in Arab World, a difference of 47.6%.
That makes Sweden's figure about 2.0 times Arab World's.
Across all 23 years both countries report, Sweden has been ahead every year.
Arab World ranks 16th and Sweden ranks 14th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Arab World | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.7% | 41.9% | 37.2% | Sweden |
| 2010s | 28.0% | 89.5% | 61.5% | Sweden |
| 2020s | 45.9% | 95.7% | 49.8% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Arab World or Sweden?
- Sweden, at 96.0% against 48.4% in Arab World as of 2022.
- What is the difference in access to anti-retroviral drugs, female between Arab World and Sweden?
- 47.6%, with Sweden ahead.
- How many years of comparable data are there for Arab World and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Arab World and Sweden rank globally for access to anti-retroviral drugs, female?
- Arab World ranks 16th and Sweden ranks 14th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.